Rafarma Pharmaceuticals, Inc. (RAFA)

Rafarma Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2012	FY 2011
Period Ending	Mar 31, 2012	Mar 31, 2012	Mar 31, 2011
Revenue Revenue Growth	0.13	0.13	0.13
Revenue Growth	-	0%	-
Operating Income Operating Income Growth	-0.11	-0.11	-0.11
Net Income Net Income Growth	-0.12	-0.12	-0.12
Earnings Per Share EPS Growth	-0.01	-0.01	-0.01
EPS Growth	-	-	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2012	FY 2011
Period Ending	Mar 31, 2012	Mar 31, 2012	Mar 31, 2011
Cash & Investments Cash & Investments Growth	0.12	0.12	0.09
Total Debt Total Debt Growth	0.24	0.24	0.23
Net Cash (Debt) Net Cash Growth	-0.12	-0.12	-0.14
Net Cash Growth	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-0.02	-0.02	-0.02

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2012	FY 2011
Period Ending	Mar 31, 2012	Mar 31, 2012	Mar 31, 2011
Operating Cash Flow Operating Cash Flow Growth	0.03	0.03	0.03
Free Cash Flow Free Cash Flow Growth	0.03	0.03	0.03
Free Cash Flow Growth	-	0%	-

Margins

Chart

Fiscal Year	TTM	FY 2012	FY 2011
Period Ending	Mar 31, 2012	Mar 31, 2012	Mar 31, 2011
Operating Margin	-81.25%	-81.25%	-81.25%
Pretax Margin	-87.92%	-87.92%	-87.92%
Profit Margin	-87.92%	-87.92%	-87.92%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2012

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every year for this company.

Update frequency:

Yearly

Last checked:

Sep 4, 2026

Data Sources Report a data error